Catalog |
name |
Description |
price |
R-M1-8006 |
Propargyl-NHS Ester,cas:1174157-65-3 |
Propargyl-NHS Ester is a simple alkyne-containing reagent that reacts with primary amines at pH 7-9 forming a stale amide bond. The terminal alkyne group reacts with azides by a mechanism known as the Cu-catalyzed click reaction enabling efficient and specific conjugation of derivatized molecules in biological samples. A short spacer arm adds minimal mass to modified molecules.
|
price> |
R-M2-9641 |
Tannic acid-TK-Polypropylene glycol 1K-TK-Adamantane |
Tannic acid-TK-Polypropylene glycol 1K-TK-Adamantane could be applied in food packaging or biomedical devices to provide anti-inflammatory, antioxidant, or antimicrobial properties through the tannic acid component.
These components together could form nanoparticles or micelles that enhance drug solubility and biocompatibility, enabling targeted therapy strategies. |
price> |
R-M1-8473 |
Cisplatin-cooh |
Cisplatin-COOH refers to a modified form of the chemotherapy drug cisplatin, where a carboxyl group (COOH) is attached to the molecule. Cisplatin itself is composed of a central platinum atom surrounded by two chloride ions and two amine (NH3) groups. It is widely used in cancer treatment due to its ability to inhibit cell division and induce cell death in rapidly dividing cancer cells. |
price> |
R-M1-8613 |
D-α-tocopheryl polyethylene glycol succinate-NHS |
D-α-tocopheryl polyethylene glycol succinate-NHS/TPGS-NHS/d-α-tocopheryl polyethylene glycol succinate (TPGS)-NHS/d-α-tocopheryl polyethylene glycol succinate N-hydroxylsuccinimide/TPGS-N-hydroxylsuccinimide can as a potential carrier for controlled delivery of the drug.TPGS can target the mitochondria of cancer cells and leads to their destruction by activating mitochondrial apoptosis mediators This anticancer activity has been shown against cancer cells only and does not affect healthy cells TPGS has been explored in combination therapy with many anticancer drugs, including DOX-loaded nanocarriers. |
price> |
R-M1-8702 |
BOC-TK-NH2 |
BOC-TK-NH2 is a chemical compound that consists of the BOC (tert-butyloxycarbonyl) protective group attached to the amino acid lysine. The abbreviation NH2 represents the amine functional group at the end of the compound.
BOC-TK-NH2 is commonly used in peptide synthesis as a protecting group to prevent unwanted reactions during the synthesis process. It can be selectively removed using specific conditions to expose the amine group for further modification or coupling reactions. |
price> |
R-M1-8703 |
Fmoc-TK-NH2 |
Fmoc-TK-NH2/Fmoc-thioketal-amine is also commonly used in peptide synthesis as a protecting group to prevent unwanted reactions during the synthesis process. Similar to BOC-TK-NH2, Fmoc-TK-NH2 can be selectively removed using specific conditions to expose the amine group for further modification or coupling reactions. The Fmoc protecting group is often removed using bases such as piperidine, which cleaves the Fmoc group and allows for subsequent reactions with the exposed amino group. |
price> |
R-M1-8704 |
FITC-TK-NH2 |
In FITC-TK-NH2/FITC-thioketal-amine/Fluorescein isothiocyanate-thioketal-NH2/Fluorescein isothiocyanate-thioketal-amine, FITC is typically attached to the ε-amine group of the lysine residue through a stable bond formation. This labeling allows for visualization or quantification of the target molecule in fluorescence-based applications such as fluorescence microscopy,flow cytometry and fluorescence-based assays.FITC-TK-NH2/FITC-thioketal-amine can be used for applications ranging from cellular imaging to protein labeling,where the fluorescence emitted by FITC allows for localization and detection of the labeled molecule. |
price> |